---
title: "1J5.SG (1J5.SG) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/1J5.SG/news.md"
symbol: "1J5.SG"
name: "1J5.SG"
parent: "https://longbridge.com/en/quote/1J5.SG.md"
datetime: "2026-03-14T11:17:22.698Z"
locales:
  - [en](https://longbridge.com/en/quote/1J5.SG/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/1J5.SG/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/1J5.SG/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/1J5.SG/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/1J5.SG/news.md)


# 1J5.SG (1J5.SG) — Related News

### [Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins](https://longbridge.com/en/news/276821357.md)
*2026-02-25T02:56:58.000Z*
> Hyphens Pharma International Limited reported a 44% drop in net profit to $6.1 million for the year ending December 31, 

### [04:30 ET
			
			
				Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries](https://longbridge.com/en/news/271489966.md)
*2026-01-05T09:30:26.000Z*
> Hyphens Pharma International Limited has out-licensed its Cerapro® MED Skin Barrier Cream to Louis Widmer SA for commerc

### [Stock Analysis: Hyphens Pharma | Lianhe Zaobao](https://longbridge.com/en/news/253996315.md)
*2025-08-21T12:29:44.000Z*
> Hyphens Pharma recommends increasing holdings, with a target price raised to 0.43 yuan, closing price at 0.305 yuan (+5.

### [Hyphens Pharma Introduces Novel Acne Treatment in Singapore, Malaysia; Shares Up Nearly 2%](https://longbridge.com/en/news/249080126.md)
*2025-07-18T05:34:51.000Z*
> Hyphens Pharma , through Hyphens Pharma International, launched Winlevi (clascoterone) cream 1% in Singapore and Malaysi